Professor Godin’s research seeks the development of microfluidic and nanofluidic technologies for biomedical applications. While we have seen great advances in chemical / biological sensing,health screening,and diagnostics in recent years,there are still some great challenges that remain to be addressed.The relevant antigen(target} concentration for various disease states often challenges the limits of detection of current technologies.The complexity of real - world samples such as blood,urine,saliva or food makes the detection of a specific disease biomarker or pathogen challenging,requiring complex sample preparation procedures.Also,the success of a sensing technology will be impacted by cost and ease of deployment in non - standard settings such in third world areas or even for bedside diagnostics.We seek to address these issues from four fronts:<br/>1) Biosensing: Development of novel assays and detection / characterization technologies <br/>2} Lab - on - a - Chip: Implementation of sample manipulation,separation and concentration platforms<br/>3} Science: Establishing a fundamental understanding of the science relevant to each sensing platforms <br/>4} Technology: Providing new quantitative measurement capabilities for conducting basic research in biology,chemistry and physics